News & Insights
At Accorto Regulatory Solutions we are always keeping a close eye on news in our areas of expertise. Stay up to date with Insights and News from Accorto Regulatory Solutions by signing up for our Newsletter!
News
November 15, 2024
November 15, 2024 | Regulatory Insights | Author: Neel Parmar For a successful FDA submission in the US medical device industry, demonstrating the [...]
July 30, 2024
July 30, 2024 - The following article was developed by Inter Scientific CEO, David Lawson, in collaboration with Accorto's Cheif Science Officer, Dr. Vince Angelico Introduction Those familiar [...]
June 11, 2024
[EINPresswire.com] LIVERPOOL, UNITED KINGDOM -- 11 JUNE 2024 -- Inter Scientific, a global, industry-leading analytical testing and regulatory compliance firm, announced today that it has completed its [...]
June 11, 2024
Press Release from the Office of Public Affairs - U.S. Department Of Justice - June 10, 2024 The Justice Department and U.S. Food and Drug Administration [...]
May 7, 2024
Information below has been directly sourced from U.S. Food and Drug Administration - CTP Newsroom April 30, 2024 Today, the U.S. Food and Drug Administration (FDA), in [...]
November 28, 2023
RICHMOND, VIRGINIA and LIVERPOOL, UNITED KINGDOM, Nov. 28, 2023 – Accorto Regulatory Solutions, LLC. (Accorto), a US-based regulatory firm specializing in helping small to mid-sized companies navigate [...]
Insights
January 5, 2022
The FDA Deficiency Letter Response Process for Premarket Tobacco Applications: How to Survive Substantive Scientific Review The Substantive Review Process: Once [...]
January 4, 2022
Your Vape PMTA & FDA's New Consumer Research Guidance On Oct 27, FDA’s Office of Science and Office of Regulation in the Center [...]
January 4, 2022
Understanding Vape PMTA Statuses If you’re following PMTA submissions, you’ve probably seen many press releases from vape companies detailing the status of their [...]
